CRIS Current Research Information System

BRILLANTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.691
AS - Asia 1.994
EU - Europa 1.495
AF - Africa 136
SA - Sud America 77
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.399
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.663
SG - Singapore 683
CN - Cina 475
VN - Vietnam 410
GB - Regno Unito 393
IT - Italia 212
DE - Germania 210
SE - Svezia 186
IN - India 126
HK - Hong Kong 121
FR - Francia 103
RU - Federazione Russa 82
UA - Ucraina 73
IE - Irlanda 59
NL - Olanda 49
BR - Brasile 47
CI - Costa d'Avorio 44
ZA - Sudafrica 43
JP - Giappone 33
EE - Estonia 32
CA - Canada 23
KR - Corea 22
TG - Togo 21
FI - Finlandia 19
PH - Filippine 18
BD - Bangladesh 17
BE - Belgio 15
AR - Argentina 14
CH - Svizzera 13
BG - Bulgaria 12
IQ - Iraq 11
TH - Thailandia 11
TW - Taiwan 11
JO - Giordania 10
NG - Nigeria 10
AT - Austria 9
PK - Pakistan 9
SC - Seychelles 9
EC - Ecuador 8
ES - Italia 7
IR - Iran 7
TR - Turchia 7
ID - Indonesia 6
PL - Polonia 6
GR - Grecia 4
SA - Arabia Saudita 4
AU - Australia 3
SI - Slovenia 3
UZ - Uzbekistan 3
CZ - Repubblica Ceca 2
ET - Etiopia 2
KE - Kenya 2
KG - Kirghizistan 2
MX - Messico 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SN - Senegal 2
VE - Venezuela 2
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
CV - Capo Verde 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
LB - Libano 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 6.399
Salva come PNG Salva come JPEG
Città #
Singapore 505
Southend 348
Ashburn 282
Fairfield 274
Chandler 162
San Jose 136
Wilmington 134
Ann Arbor 121
Hong Kong 114
Houston 113
Woodbridge 112
Ho Chi Minh City 107
Santa Clara 107
Seattle 99
Boardman 82
Cambridge 78
Princeton 78
Hanoi 77
Beijing 68
Dallas 61
Dublin 58
Hefei 49
Abidjan 44
Jacksonville 42
New York 37
Bologna 36
Nanjing 36
Westminster 34
Lauterbourg 33
Los Angeles 33
Tokyo 33
Padova 29
Dong Ket 25
Milan 22
Saint Petersburg 22
Lomé 21
Medford 20
Buffalo 19
Da Nang 19
Frankfurt am Main 19
Dearborn 16
Shenyang 16
Bremen 15
Brussels 15
Florence 15
Haiphong 15
San Diego 15
Berlin 14
Munich 14
Guangzhou 13
Seoul 13
Falls Church 12
Monmouth Junction 12
Redondo Beach 12
Helsinki 11
Tianjin 11
Abeokuta 10
Amman 10
Changsha 10
Council Bluffs 10
Johannesburg 10
Sofia 10
Jinan 9
Mülheim 9
Redmond 9
Bern 8
Can Tho 8
London 8
Redwood City 8
Shanghai 8
Bari 7
Dolo 7
Norwalk 7
Phoenix 7
São Paulo 7
Toronto 7
Turin 7
Turku 7
Washington 7
Biên Hòa 6
Des Moines 6
Hangzhou 6
Hebei 6
Hải Dương 6
Jiaxing 6
Lahore 6
Montreal 6
Nanchang 6
San Francisco 6
Wuhan 6
Yubileyny 6
Ardabil 5
Baghdad 5
Brooklyn 5
Falkenstein 5
Forlì 5
Fuzhou 5
Lake Forest 5
Moscow 5
Orem 5
Totale 4.215
Salva come PNG Salva come JPEG
Nome #
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 217
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 216
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 212
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 203
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 202
Reactivation of Crohn's disease after pandemic aH1N1 and seasonal flu vaccinations. 197
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 195
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 191
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 189
Ribavirin for chronic hepatitis C: And the mystery goes on. 186
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 180
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 175
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 175
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 172
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. 172
Role of amantadine and other adjuvant therapies in the treatment of hepatitis C. 171
Terapia cellulare in Epatologia 171
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 168
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 167
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 158
Proctosigmoidite ulcerosa refrattaria e recidivante alla terapia topica trattata con beclometasone dipropionato orale 157
Loss and seroconversion of hepatitis B surface antigen after vaccine therapy in chronic hepatitis B patients treated with nucleoside/nucleotide analogues. 154
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum 153
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. 149
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 149
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. 137
Severe acute autoimmune hepatitis after natalizumab treatment. 135
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 134
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 131
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 131
RIBAVIRIN PRIMING ENHANCES EFFICACY OF CHRONIC HEPATITIS C RE-TREATMENT IN PATIENTS WHO HAD NOT RESPONDED TO PREVIOUS COMBINATION THERAPY 129
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project 128
Trattamento della Epatite da HCV 128
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 120
A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy 120
Enhanced response to peginterferon-alpha-2a based triple therapy in previously non-responsive chronic hepatitis C: Final results of PRETTY study. 118
VIROLOGICAL FAILURES TO NEW DIRECT ACTING ANTIVIRALS IN A REAL LIFE SETTING MAY REQUIRE UNCONVENTIONAL REGIMENS FOR RE-TREATMENT 111
null 107
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC. 102
La ribavirina nell'epatite cronica C: storia e segreti di un grande successo. 97
null 96
Low recurrence rate of hepatocellular carcinoma after liver transplantation: Better patient selection or lower immunosuppression? 67
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 28
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 27
Totale 6.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021111 0 0 0 0 0 0 0 0 0 0 29 82
2021/2022829 42 39 33 53 71 49 15 39 30 47 291 120
2022/2023721 74 84 40 106 59 63 16 40 122 17 59 41
2023/2024236 12 48 16 17 31 50 10 9 25 4 1 13
2024/2025899 39 149 86 57 154 42 54 28 1 66 29 194
2025/20262.044 179 130 191 127 224 123 224 123 504 159 60 0
Totale 6.525